Clinical Trials Logo

Skin Diseases clinical trials

View clinical trials related to Skin Diseases.

Filter by:

NCT ID: NCT01012453 Recruiting - Eczema Clinical Trials

A Randomised Clinical Trial in a Population of Health Care Workers With Hand Eczema

HET
Start date: October 2009
Phase: N/A
Study type: Interventional

Objectives and perspective: 1. To estimate the prevalence of hand eczema in a cohort of health care workers and assess exposures in the hospital environment that can lead to hand eczema . To investigate the knowledge of skin protection among health care workers. 2. To classify subtypes of hand eczema, assess severity of hand eczema and quality of life in health care workers with hand eczema 3. To evaluate the effect of a combination of classification of hand eczema and individual work-related counseling in skin protective behavior. The overall perspective of the trial is to develop new strategies for prevention of occupational hand eczema in health care workers. Hypotheses: - Irritant contact dermatitis is more common than allergic contact dermatitis. - The combination of precise classification (subtyping of HE) and individual counseling will have a positive impact on the prognosis of hand eczema. - The positive impact on the prognosis of hand eczema will have a positive impact on quality of life (QoL). - The knowledge of protective behavior will increase. - Education in a skin care program will have a positive impact on skin protective behavior.

NCT ID: NCT00997997 Completed - Clinical trials for Skin Diseases, Bacterial

Avelox in Complicated Skin and Skin Structure Infections

ARTOS
Start date: October 2005
Phase: N/A
Study type: Observational

This international, prospective, non-interventional, non-controlled observational study obtains data on efficacy, safety and tolerability of Avelox treatment under daily-life treatment conditions. Specifically investigated are the improvement of clinical symptoms and the duration until infection improvement and cure.Any patient with a diagnosis of complicated skin and skin structure infection (cSSSI) treated with Avelox can be documented. The observation period for each subject covers the treatment period with Avelox. For each patient, the physician documents data at an initial visit and one or two follow-up visit(s) in line with routine practice.

NCT ID: NCT00990392 Withdrawn - Clinical trials for Skin Diseases, Infectious

Topical Antibiotics for Prevention of Intensive Care Unit (ICU) Central Line Infections

ToPICL
Start date: November 2009
Phase: N/A
Study type: Interventional

The purpose of the study is to determine if the overall central venous catheter related infection rate can be reduced by the application of Polysporin Triple Therapy ointment to the insertion site.

NCT ID: NCT00948142 Completed - Clinical trials for Skin Diseases, Bacterial

Safety and Efficacy of CEM-102 Compared to Linezolid in Acute Bacterial Skin Infections

Start date: August 2009
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine the safety and efficacy of CEM-102 compared to Linezolid in the treatment of acute bacterial skin structure infections (ABSSIs).

NCT ID: NCT00936546 Completed - Clinical trials for Debilitating Fibrosing Skin Disorders (Localised Scleroderma, Eosinophilic Fasciitis)

A Protocol Based Treatment for Debilitating Fibrosing Skin Disorders With (Anti-CD 20), Rituximab, Evaluating Safety and Efficacy

Start date: June 2009
Phase: Phase 2
Study type: Interventional

This study will evaluate the safety and efficacy of the combination of rituximab and methotrexate to treat disabling fibrosing skin disorders.Rituximab will be administered at baseline and month 6. The drug will be considered efficacious if the skin thickness diminishes substantially.

NCT ID: NCT00911573 Withdrawn - Infection Clinical Trials

Study Evaluating Tigecycline Versus Clindamycin Or Vancomycin On Complicated Skin And Skin Structure Infections Including Those Due To Methicillin-Resistant Staphylococcus Aureus (MRSA) In Pediatric Subjects

Start date: August 2011
Phase: Phase 3
Study type: Interventional

The main purpose of this study is to compare the safety and efficacy of tigecycline versus clindamycin (including subjects treated with vancomycin) in pediatric subjects (aged 8 to 17 years) with complicated skin and skin structure infections (cSSSI), including those caused by methicillin-resistant staphylococcus aureus (MRSA).

NCT ID: NCT00910260 Completed - Skin Disease Clinical Trials

Impact on UVB Narrow Band and UVA1 Therapy on Serum 25-hydroxyvitamin D Levels

Start date: March 2009
Phase: Phase 4
Study type: Observational

We plan to investigate the serum elevation of 25(OH)D under UVB nb and UVA1 therapy, in order to determine the effect of these nowadays frequently used wavelengths for phototherapy on vitamin D plasma levels. We hope for a better understanding of steady-state and treatment-induced levels of vitamin D changes to better recognize the impact of phototherapy on vitamin D synthesis in the skin, the dimension of vitamin D production to be expected in the course of standard phototherapy and a potential gap in vitamin D production compared to physiological needs which then should be supplemented orally.

NCT ID: NCT00865280 Terminated - Clinical trials for Skin Diseases, Infectious

Study the Safety and Efficacy of PTK 0796 in Patients With Complicated Skin and Skin Structure Infection (CSSSI)

CSSI
Start date: April 4, 2009
Phase: Phase 3
Study type: Interventional

A Phase III trial to demonstrate the safety and efficacy of PTK 0796 in the treatment of complicated skin and skin structure infections (cSSSI).

NCT ID: NCT00847912 Completed - Carcinoma Clinical Trials

CSP #562 - The VA Keratinocyte Carcinoma Chemoprevention Trial

VAKCCT
Start date: June 26, 2009
Phase: Phase 4
Study type: Interventional

The main purpose of this study is to see if 5-fluorouracil (5-FU) skin cream can prevent the growth of new skin cancers on the face and ears. The cost of trying to prevent skin cancer will be compared to the usual cost of treating skin cancer. Participants are being asked to be a part of this study because the participants have been treated for two or more skin cancers within the past five (5) years. At least one of these cancers occurred on the face or ears. Having had two or more skins cancers in the past 5 years makes it likely that participants will develop additional skin cancers in the future. Exposure to ultraviolet radiation from the sun or artificial sources such as tanning beds is a major cause of basal cell and squamous cell carcinoma of the skin. Using lotions, creams, or gels that contain sunscreens can help protect the skin from premature aging and damage that may lead to skin cancer. The 5-FU skin cream used in this study is FDA-approved to treat some types of skin cancers and spots that might become skin cancer. However, 5-FU skin cream has never been studied to see if it can prevent skin cancer. This drug is not approved by the FDA for how it will be used in this study. In this study, one half of the patients will use the 5-FU cream and the other half will use a skin cream that looks identical to the 5-FU cream but does not have 5-FU or any other active drug in it. Approximately twelve VA medical centers will work together in this study. About one thousand (1000) patients will be in this study. The study is sponsored by the U.S. Department of Veterans Affairs Cooperative Studies Program.

NCT ID: NCT00843466 Completed - Hand Dermatosis Clinical Trials

Compatibility of a Mild, Moisturizing Hand Cleanser for Patients With Mild to Moderate Hand Dermatitis

Start date: May 2007
Phase: N/A
Study type: Interventional

The purpose of this study is to find out if the use of a hand cleanser that adds moisture to the skin will help improve skin rashes caused by frequent hand washing (hand dermatitis).